Here’s a thoughtful look at the growing recreational use of magic mushrooms in the UK—exploring the data, public perception, risks, and what it means for policy and public health. Related news on this topic The Scottish Sun How ‘magic mushrooms’ could transform medicine – from treating depression to gambling and addiction Oct 7, 2024 Scale…
The University College London (UCL) is conducting a pioneering clinical trial to assess the potential of Dimethyltryptamine (DMT) in reducing alcohol consumption among heavy drinkers. This study, known as the Understanding Neuroplasticity Induced by TrYptamines (UNITy) project, represents the largest psychedelic brain imaging study of its kind to date and is funded by Wellcome Leap…
What is 5‑MeO‑DMT? 5‑Methoxy-N,N-Dimethyltryptamine (5‑MeO‑DMT) is a powerful, fast-acting psychedelic compound found in certain toads (notably the Colorado River toad) and plants. It produces an intense, short-lived (typically 20–60 minutes) mystical experience characterized by ego dissolution, profound unity, and spiritual insights. Unlike psilocybin or LSD, 5‑MeO‑DMT is notable for its: GH Research and 5‑MeO‑DMT in…
When most people think of psychedelics, they picture a mushroom-fueled inward journey or a clinical psilocybin session led by a soft-spoken therapist. But the future of psychedelic therapy is expanding far beyond that. We’re entering a new era—where AI-driven integration tools, virtual reality environments, and wearable neurotech are merging with psychedelic medicine to enhance treatment,…
Psychedelic therapy is no longer a fringe idea—it’s entering the UK’s medical mainstream. From psilocybin for depression to DMT for alcohol misuse, leading institutions like King’s College London, UCL, and Imperial College are running groundbreaking trials. But while the science is advancing fast, the UK’s “nervous system”—its NHS infrastructure, clinicians, policymakers, and training bodies—lags behind….
1. Regulatory & Legal Barriers—Schedule I Status Holds Back Psychedelic Progress Why it matters: Reforming scheduling could be a game-changer—drastically lowering barriers for clinical research, enabling broader NHS involvement, and paving the way for future authorization. 2. Institutional Foundation & Growing Infrastructure Why it matters: This dedicated centre signifies that psychedelics are advancing from fringe…
1. DMT Trial for Alcohol Misuse (UCL) Researchers at University College London have launched the largest psychedelic brain-imaging study to date. They’re investigating whether a single intravenous dose of DMT can help reduce alcohol consumption by targeting alcohol-related reward memories. The study involves 120 volunteers and combines MRI brain scans with controlled reactivation of those…
The Stamets Stack is a nootropic and microdosing regimen designed to support neurogenesis, cognitive clarity, focus, and overall brain health by combining three key components: Why These Three? Protocol Overview Typical dosing schedule: What Users Report (Anecdotal) Here’s what some community members have shared: “I use them 3‑4 days on and 2‑3 days off every week. It…
Introduction Psilocybin—the psychoactive compound found in “magic mushrooms”—has gained scientific attention for its profound effects on consciousness and mental health. Cutting-edge research from institutions like Imperial College London and Johns Hopkins has begun to map how it alters brain function, promotes neuroplasticity, and may support therapeutic outcomes. 1. Brain Connectivity & Ego Dissolution Disruption of…
The demand for magic mushrooms in the UK has grown rapidly in recent years, as more people explore their potential for wellness, creativity, and self-discovery. While laws around psilocybin remain strict, interest in legal functional mushrooms and research into therapeutic applications continues to rise. At the center of this movement, Wild Team is redefining what…
No products in the basket.